Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5739016 | 1.00 | TSHR (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2688287 | 0.98 | TSHR (0.65) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18822943 | 0.98 | TSHR (0.65) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2689893 | 0.98 | TSHR (0.65) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18822989 | 0.98 | TSHR (0.65) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18822941 | 0.98 | TSHR (0.65) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL278570 | 0.96 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL11096017 | 0.92 | TSHR (0.77) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL17785972 | 0.91 | TSHR (0.66) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2880688 | 0.88 | THRB (0.57) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11987715-B2 | Radiation curable ink jet composition and ink jet method | SEIKO EPSON CORPORATION (JP) | 2024-05-21 | — | — | US | disclosed |
| US-11965094-B2 | Curable organopolysiloxane compositions | WACKER CHEMIE AG (DE) | 2024-04-23 | — | — | US | disclosed |
| US-20240052185-A1 | Radiation Curable Ink Jet Composition And Ink Jet Method | SEIKO EPSON CORP (JP) | 2024-02-15 | — | — | US | disclosed |
| US-11884828-B2 | Radiation curable ink jet composition and ink jet method | SEIKO EPSON CORPORATION | 2024-01-30 | — | — | US | disclosed |
| EP-3885413-B1 | RADIATION CURABLE INK JET COMPOSITION AND INK JET METHOD | SEIKO EPSON CORP (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-20230203275-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2023-06-29 | — | — | US | disclosed |
| US-11421108-B2 | Curable organopolysiloxane compositions | WACKER CHEMIE AG (DE) | 2022-08-23 | — | — | US | disclosed |
| EP-3642284-B1 | CURABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2022-06-01 | — | — | EP | disclosed |
| US-20210301162-A1 | Radiation Curable Ink Jet Composition And Ink Jet Method | SEIKO EPSON CORPORATION (JP) | 2021-09-30 | — | — | US | disclosed |
| US-20210301158-A1 | Radiation Curable Ink Jet Composition And Ink Jet Method | SEIKO EPSON CORPORATION (JP) | 2021-09-30 | — | — | US | disclosed |
| US-20070111136-A1 | Photosensitive resin composition, photosensitive element employing it, resist pattern forming method, process for manufacturing printed circuit board and method for removing photocured product | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2007-05-17 | — | — | US | disclosed |
| US-20070049768-A1 | COMPOSITION OF VINYL ETHER GROUP CONTAINING (METH) ACRYLIC ACID ESTER AND PRODUCTION METHOD THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-03-01 | — | — | US | disclosed |
| EP-1561792-B1 | New ink compositions for ink jet printing | AGFA GEVAERT (BE) | 2006-08-30 | — | — | EP | disclosed |
| EP-1561792-A1 | New ink compositions for ink jet printing | Agfa-Gevaert (BE) | 2005-08-10 | — | — | EP | disclosed |
| EP-1505090-A1 | REACTIVE DILUENT COMPOSITION AND CURABLE RESIN COMPOSITION | Nippon Shokubai Co., Ltd. (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-6767980-B2 | ACTIVATED ENERGY RAY-CURABLE INK COMPOSITION FOR INK-JET PRINTING; VINYL ETHER GROUP-CONTAINING (METH)ACRYLIC ESTER | NIPPON SHOKUBAI CO., LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030199655-A1 | Reactive diluent and curable resin composition | NIPPON SHOKUBAI CO., LTD. | 2003-10-23 | — | — | US | disclosed |
| US-20020143120-A1 | Composition of vinyl ether group-containing (meth) acrylic acid ester and production method thereof | NIPPON SHOKUBAI CO., LTD. | 2002-10-03 | — | — | US | disclosed |
| EP-1201641-A2 | Composition of vinyl ether group containing (meth)acrylic acid ester and production method thereof | Nippon Shokubai Co., Ltd. (JP) | 2002-05-02 | — | — | EP | disclosed |
| US-5914427-A | Preparation of ω-hydroxyesiers of α,β-unsaturated carboxylic acids | BASF AKTIENGESELLSHAFT (DE) | 1999-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049768-A1 | COMPOSITION OF VINYL ETHER GROUP CONTAINING (METH) ACRYLIC ACID ESTER AND PRODUCTION METHOD THEREOF | MMAB, ME1, PRMT1 | TSHR 2551/4885THRB 1335/4885POLB 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.